Fact sheet: Variopartner SICAV SeBiOpp

Fund information

Fund name
Variopartner SICAV Sectoral Biotech Opportunities I USD
Fund company manager
Vontobel Asset Management S.A.
Fund type
SIB
Fund manager
Stephan Patten
since 27/02/2015
Fund objective
While respecting the principle of risk diversification, the Sub-Fund's assets are primarily invested in shares, equity-like transferable securities, participation certificates etc. issued by companies worldwide which are active in the generics sector. No geographical restrictions apply re. specific countries or regions.
Benchmark
Nasdaq Biotech Index
Investment style
None
Investment method
Shares

Quick stats

1 Year return

26.7 %

1 Year rank in sector

1/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 114.5 m

FE Risk score

241

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    81.7%
  • Money Market
    5.4%
  • France
    4.4%
  • Israel
    4%
  • Switzerland
    1.9%
  • Biotechnology/Medical
    81.6%
  • Pharmaceuticals
    13%
  • Money Market
    5.4%
  • US Equities
    81.7%
  • Money Market
    5.4%
  • French Equities
    4.4%
  • Israeli Equities
    4%
  • Swiss Equities
    1.9%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-6.16 %18.02 %26.7 %0 %0 %
Sector-4.94 %1.81 %5.34 %20.5 %96.8 %
Rank within sector23 / 301 / 291 / 29 / /
Quartile th4 th1 st1 st th th

Calendar performance

YTD-20172016201520142013
Fund35.77 %-22.42 %0 %0 %0 %
Sector10.78 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector1 / 2927 / 29 / / /
Quartile th1 st4 th th th th

Price movement

52 week high10.05
52 week low6.48
Current bid price0
Current offer price0
Current mid price9.3

Holdings by region

  • 81.7% USA
  • 5.4% Money Market
  • 4.4% France
  • 4% Israel
  • 1.9% Switzerland
  • 1.8% Sweden
  • 0.8% Canada

Holdings by sector

  • 81.6% Biotechnology/Medical
  • 13% Pharmaceuticals
  • 5.4% Money Market

Holdings by asset type

  • 81.7% US Equities
  • 5.4% Money Market
  • 4.4% French Equities
  • 4% Israeli Equities
  • 1.9% Swiss Equities
  • 1.8% Swedish Equities
  • 0.8% Canadian Equities

Individual holdings

  • 6.6% AMICUS THERAPEUTICS
  • 6.1% REGENERON PHARMACEUTICALS INC
  • 4.7% ACADIA PHARMACEUTICALS INC
  • 4.7% AERIE PHARMACEUTICALS INC
  • 4.2% LA JOLLA PHARMACEUTICAL CO
  • 4% ALBIREO PHARMA INC
  • 4% NEURODERM LTD
  • 4% PORTOLA PHARMACEUTICALS INC
  • 3.6% BIOMARIN PHARMACEUTICAL
  • 3.6% CELGENE CORP